Please assess the completion status of the following clinical trial:

Trial Title: Molecular Imaging of Breast Cancer With Breast PET/CT

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~- Normal Adult Volunteers~* Female, at least 18 years of age~* Ability to lie motionless for up to 20 minutes~Patient Volunteers~* Female, at least 18 years of age~* Diagnostic findings from prior mammography highly suggestive of invasive breast carcinoma (BI-RADS category 5)~* Not pregnant or breast-feeding~* Ability to lie motionless for up to 20 minutes~Exclusion Criteria:~* Normal Adult Volunteers~  * Inability to understand the risks and benefits of the study~Patient Volunteers~* Recent breast biopsy~* Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or lobular carcinoma~* Uncontrolled diabetes~* Diabetic and blood sugar level \> 200 mg/dL~* Positive urine pregnancy test or currently breast-feeding~* Inability to understand the risks and benefits of the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: OTHER): Normal volunteers
- 2 (Type: ACTIVE_COMPARATOR): Breast PET/CT scan
- 3 (Type: ACTIVE_COMPARATOR): Whole body and breast PET/CT

Based on this trial design, predict the completion outcome and termination type (if applicable).